Trial
NCT03028129
Prevention of Tuberculosis in Prisons
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Federal University of Mato Grosso
Collaborators
Oswaldo Cruz Foundation
Condition
Tuberculosis, Pulmonary
Intervention
Isoniazid 900 milligrams
Why stopped
Interim analysis showed efficacy less than 2.5%.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-25